SAB Biotherapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 114.70K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, SAB Biotherapeutics had annual revenue of 1.32M with -40.94% growth.